{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:09Z","timestamp":1772165709173,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ek0109549"],"award-info":[{"award-number":["22ek0109549"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Familial encephalopathy with neuroserpin inclusion bodies (FENIB) is a rare genetic disorder characterized by progressive cognitive decline and myoclonic epilepsy, caused by pathogenic variants of\n                      <jats:italic>SERPINI1<\/jats:italic>\n                      . We reported a case of genetically confirmed FENIB with de novo H338R mutation in the\n                      <jats:italic>SERPINI1<\/jats:italic>\n                      , in which frontal deficits including inattention and disinhibition, and relevant atrophy in the vmPFC on brain MRI were observed in the early stage of the disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 23-year-old Japanese man presented with progressive inattention and disinhibition over 4 years followed by myoclonic epilepsy. The whole-genome sequencing and filtering analysis showed de novo heterozygous H338R mutation in the\n                      <jats:italic>SERPINI1<\/jats:italic>\n                      , confirming the diagnosis of FENIB. Single-case voxel-based morphometry using brain magnetic resonance imaging obtained at the initial visit revealed focal gray matter volume loss in the ventromedial prefrontal cortices, which is presumed to be associated with inattention and disinhibition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Frontal deficits including inattention and disinhibition can be the presenting symptoms of patients with FENIB. Single-case voxel-based morphometry may be useful for detecting regional atrophy of the frontal lobe in FENIB. Detecting these abnormalities in the early stage of disease may be key findings for differentiating FENIB from other causes of progressive myoclonic epilepsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03511-0","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T01:02:37Z","timestamp":1704157357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Hideo","family":"Handa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Aotsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00018-022-04185-6","volume":"79","author":"A Godinez","year":"2022","unstructured":"Godinez A, Rajput R, Chitranshi N, et al. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological Disease. Cell Mol Life Sci. 2022;79:172.","journal-title":"Cell Mol Life Sci"},{"key":"3511_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/archneur.58.9.1429","volume":"58","author":"CB Bradshaw","year":"2001","unstructured":"Bradshaw CB, Davis RL, Shrimpton AE, et al. Cognitive deficits associated with a recently reported familial neurodegenerative Disease: familial encephalopathy with neuroserpin inclusion bodies. Arch Neurol. 2001;58:1429\u201334.","journal-title":"Arch Neurol"},{"key":"3511_CR3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/hmg\/ddn041","volume":"17","author":"E Miranda","year":"2008","unstructured":"Miranda E, MacLeod I, Davies MJ, et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the Dementia FENIB. Hum Mol Genet. 2008;17:1527\u201339.","journal-title":"Hum Mol Genet"},{"key":"3511_CR4","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/S0140-6736(02)09293-0","volume":"359","author":"RL Davis","year":"2002","unstructured":"Davis RL, Shrimpton AE, Carrell RW, et al. Association between conformational mutations in neuroserpin and onset and severity of Dementia. Lancet. 2002;359:2242\u20137.","journal-title":"Lancet"},{"key":"3511_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1212\/01.wnl.0000265052.99144.b5","volume":"69","author":"I Gourfinkel-An","year":"2007","unstructured":"Gourfinkel-An I, Duyckaerts C, Camuzat A, et al. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene. Neurology. 2007;69:79\u201383.","journal-title":"Neurology"},{"key":"3511_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jnen\/59.12.1070","volume":"59","author":"M Takao","year":"2000","unstructured":"Takao M, Benson MD, Murrell JR, et al. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with Progressive myoclonus Epilepsy. J Neuropathol Exp Neurol. 2000;59:1070\u201386.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3511_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jns.2017.11.029","volume":"384","author":"H Amano-Takeshige","year":"2018","unstructured":"Amano-Takeshige H, Oyama G, Kanai K, et al. A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: a case report. J Neurol Sci. 2018;384:126\u20138.","journal-title":"J Neurol Sci"},{"key":"3511_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1750-3639.2011.00481.x","volume":"21","author":"MC Hagen","year":"2011","unstructured":"Hagen MC, Murrell JR, Delisle MB, et al. Encephalopathy with neuroserpin inclusion bodies presenting as Progressive myoclonus Epilepsy and associated with a novel mutation in the proteinase inhibitor 12 gene. Brain Pathol. 2011;21:575\u201382.","journal-title":"Brain Pathol"},{"key":"3511_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.seizure.2022.11.008","volume":"103","author":"X Yang","year":"2022","unstructured":"Yang X, Fang Z, Yan L, et al. Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: a case report and literature review. Seizure. 2022;103:137\u201347.","journal-title":"Seizure"},{"key":"3511_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.seizure.2020.06.022","volume":"80","author":"B Kara","year":"2020","unstructured":"Kara B, Sar\u0131kaya CE, Bayrak YE, et al. Early-onset rapidly Progressive myoclonic Epilepsy associated with G392R likely pathogenic variant in SERPINI1. Seizure. 2020;80:181\u20132.","journal-title":"Seizure"},{"key":"3511_CR11","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/ajmg.a.38317","volume":"173","author":"E Ranza","year":"2017","unstructured":"Ranza E, Garcia-Tarodo S, Varvagiannis K, et al. SERPINI1 pathogenic variants: an emerging cause of childhood-onset Progressive myoclonic Epilepsy. Am J Med Genet A. 2017;173:2456\u201360.","journal-title":"Am J Med Genet A"},{"key":"3511_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neulet.2005.03.038","volume":"382","author":"Y Hirata","year":"2005","unstructured":"Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer\u2019s Disease from controls. Neurosci Lett. 2005;382:269\u201374.","journal-title":"Neurosci Lett"},{"key":"3511_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/jpm13030419","volume":"13","author":"Y Shigemoto","year":"2023","unstructured":"Shigemoto Y, Sato N, Maikusa N, et al. Age and sex-related effects on single-subject gray matter networks in healthy participants. J Pers Med. 2023;13:419.","journal-title":"J Pers Med"},{"key":"3511_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.seizure.2019.08.012","volume":"71","author":"A Orsini","year":"2019","unstructured":"Orsini A, Valetto A, Bertini V, et al. The best evidence for Progressive myoclonic Epilepsy: a pathway to precision therapy. Seizure. 2019;71:247\u201357.","journal-title":"Seizure"},{"key":"3511_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/WNL.0b013e3181c0d427","volume":"73","author":"R Migliaccio","year":"2009","unstructured":"Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73:1571\u20138.","journal-title":"Neurology"},{"key":"3511_CR16","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.neurobiolaging.2011.12.025","volume":"33","author":"R Migliaccio","year":"2012","unstructured":"Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33:2572\u201384.","journal-title":"Neurobiol Aging"},{"key":"3511_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuroimage.2010.01.005","volume":"50","author":"K Franke","year":"2010","unstructured":"Franke K, Ziegler G, Kl\u00f6ppel S, Gaser C, Alzheimer\u2019s Disease Neuroimaging Initiative. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters. NeuroImage. 2010;50:883\u201392.","journal-title":"NeuroImage"},{"key":"3511_CR18","doi-asserted-by":"publisher","first-page":"e01020","DOI":"10.1002\/brb3.1020","volume":"8","author":"I Beheshti","year":"2018","unstructured":"Beheshti I, Maikusa N, Matsuda H. The association between brain-age score (BAS) and traditional neuropsychological screening tools in Alzheimer\u2019s Disease. Brain Behav. 2018;8:e01020.","journal-title":"Brain Behav"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03511-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:33:11Z","timestamp":1704202391000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03511-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3563342\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the clinical details was obtained from the patient\u2019s parent and brother.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}